A new study reveals that the dangerous gut bacterium Clostridioides difficile (C. diff) can quickly develop resistance to vancomycin, the primary antibiotic used to treat infections. However, this resistance comes with tradeoffs for the bacteria, making it less efficient at growing and spreading. The findings highlight the urgent need for careful monitoring of antibiotic resistance in hospitals to prevent the emergence of untreatable C. diff infections.
